Replies to post #11981 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Let me guess...didn't get the pm at 10:54?

Algernon excerpt

after its second meeting and review, the external Data and Safety Monitoring Board (“DSMB”) has once again unanimously approved the continuation of the Company’s multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The DSMB is a committee of clinical research experts, including physicians, statisticians, and patient advocates, who are monitoring the progress of the Company’s clinical trial, and are reviewing safety and effectiveness data while the trial is ongoing.

There is ZERO ambiguity in what the company has stated.

Full enrollment of phase 2b has yet to be achieved.

A phase 2b data readout is thus far expected in December 2020.

Just sayin...I'm not here to 'bully' the message board.

Peace & GL2ALL@AGNPF

/////AMG